Literature DB >> 22668567

[Reproducibility and reliability of a 4-day HBPM protocol with and without first day measurements].

Jessica Barochiner1, Paula E Cuffaro, Lucas S Aparicio, Cristina M Elizondo, Diego H Giunta, Marcelo A Rada, Margarita S Morales, José Alfie, Carlos R Galarza, Gabriel D Waisman.   

Abstract

HBPM guidelines state that morning and evening measurements should be recorded and, to improve stability, the first day of measurements should be discarded. Our objective was to assess the reproducibility and reliability of a 4-day HBPM protocol with and without first day measurements. We analyzed a retrospective cohort of ambulatory patients who required a HBPM for diagnostic purposes or evaluation of treatment efficacy. A 4-day protocol was implemented, with daily duplicate measurements in the morning, afternoon and evening, using an OMRON 705 CP validated equipment. HBPM reproducibility was quantified by test-re-test correlations and standard deviation of differences (SDD) between BP measurements obtained during the entire 4 days, with and without exclusion of the first day. The reliability criterion was the stabilization of the mean and standard deviation (SD). We included 353 subjects with a total of 8224 BP recordings (median of 24 recordings per patient). We found a strong test-re-test correlation between days 1 to 4, which improved when we excluded the first day (p<0.001). We also found a reduction of the mean BP when we increased the number of days and a reduction of SDD when we excluded day 1. Therefore, we conclude that the exclusion of the first day of measurements improves the reproducibility and reliability of a 4-day protocol, and such two factors are not affected by the inclusion of afternoon measurements.

Entities:  

Mesh:

Year:  2011        PMID: 22668567

Source DB:  PubMed          Journal:  Rev Fac Cien Med Univ Nac Cordoba        ISSN: 0014-6722


  6 in total

1.  Relationship between office and home blood pressure with increasing age: The International Database of HOme blood pressure in relation to Cardiovascular Outcome (IDHOCO).

Authors:  Angeliki Ntineri; George S Stergiou; Lutgarde Thijs; Kei Asayama; José Boggia; Nadia Boubouchairopoulou; Atsushi Hozawa; Yutaka Imai; Jouni K Johansson; Antti M Jula; Anastasios Kollias; Leonella Luzardo; Teemu J Niiranen; Kyoko Nomura; Takayoshi Ohkubo; Ichiro Tsuji; Christophe Tzourio; Fang-Fei Wei; Jan A Staessen
Journal:  Hypertens Res       Date:  2016-04-07       Impact factor: 3.872

2.  Reproducibility of masked uncontrolled hypertension detected through home blood pressure monitoring.

Authors:  Jessica Barochiner; María Lourdes Posadas Martínez; Rocío Martínez; Diego Giunta
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-06-19       Impact factor: 3.738

3.  Determinants of the Morning-Evening Home Blood Pressure Difference in Treated Hypertensives: The HIBA-Home Study.

Authors:  Lucas S Aparicio; Jessica Barochiner; Paula E Cuffaro; José Alfie; Marcelo A Rada; Margarita S Morales; Carlos R Galarza; Marcos J Marín; Gabriel D Waisman
Journal:  Int J Hypertens       Date:  2014-12-14       Impact factor: 2.420

4.  Novel Indices of Home Blood Pressure Variability and Hypertension-Mediated Organ Damage in Treated Hypertensive Patients.

Authors:  Jessica Barochiner; Rocío Martínez; Lucas S Aparicio
Journal:  High Blood Press Cardiovasc Prev       Date:  2021-04-21

5.  Prognostic value of home blood pressure monitoring in patients under antihypertensive treatment.

Authors:  Jessica Barochiner; Lucas S Aparicio; Rocío Martínez; José Boggia
Journal:  J Hum Hypertens       Date:  2022-09-26       Impact factor: 2.877

6.  Arterial Stiffness in Treated Hypertensive Patients With White-Coat Hypertension.

Authors:  Jessica Barochiner; Lucas S Aparicio; José Alfie; Margarita S Morales; Paula E Cuffaro; Marcelo A Rada; Marcos J Marin; Carlos R Galarza; Gabriel D Waisman
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-09-28       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.